Related Experiment Video
Updated: Feb 28, 2026
Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018
Improvement of Thermal Stability of BCG Vaccine
Fatemeh Jahanbakhsh Sefidi1, Homan Kaghazian2, Gholam Ali Moradli1
1Department of Microbiology, College of Basic Science, Islamic Azad University, Saveh, Iran.
Background:
Thermal stability (TS) is a part of the BCG vaccine characterization by which the consistency of process in BCG vaccine production could be confirmed. To enhance the TS of the vaccine, some prevalent stabilizers in different concentrations were added to the final formulation of BCG bulk prior to Freeze-drying process. We found a formulation more effective than the current stabilizer for retaining the higher viability of lyophilized BCG vaccine produced by Pasteur Institute of Iran.
Methods:
In the design of experiments using Taguchi method, lactose, trehalose, glucose, dextran, and monosodium glutamate were added to the final formulation of BCG bulk prior to freeze-drying process. Viability of the samples was determined by counting the colony forming unit.
Results:
Maximum signal-to-noise ratio equal to maximum TS and viability was obtained by adding lactose, dextran, and glutamate in defined concentrations.
Conclusion:
Adding the stabilizers had a significant impact on TS of BCG vaccine to meet the quality requirements.
More Related Videos
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Related Concept Videos
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
01:51Vaccinations